PharmiWeb.com - Global Pharma News & Resources
11-Jul-2019

Tumor Ablation Market Size Poised to Touch USD 3.2 Billion by 2026

The global Tumor Ablation Market Size to touch valuation around USD 3.2 billion by 2026, this market is anticipated to grow with 12.1% CAGR during the forecast time period 2018 to 2026.

Growing cases of cancer across the world is the key development-boosting factor for this industry. Around 14.0% of the populace suffers from cancer each year, according to the statistics by the (WHO) World Health Organization.

Need for slightly invasive processes owing to the advantages, for instance, speedy recovery, less trauma, along with technical progressions in the field of thermal ablation is also expected to increase market development. Such are instance, usage of cooled radiofrequency denervation method - a process, which usages radiofrequency thermal energy to ablate sensory nerve fibers of the sacroiliac joint - with internally cooled radiofrequency probes to increase the lesion size.

SonaCare Medical LLC introduced a remote patient monitoring platform; Sonalink in February 2015, that can be used during (HIFU) High-Intensity Focused Ultrasound procedures. Also, growing per capita income is allowing people to take up progressive cure for tumors, therefore boosting the development of this market. Active role of healthcare agencies and government in producing consciousness about numerous cancer types is also anticipated to facilitate usage of tumor ablation therapy, thus supporting market growth.

The global tumor ablation market is segmented into technology, treatment, application and region.

On the basis of technology, the global tumor ablation market is segmented into radiofrequency, microwave, and cryoablation. On the basis of treatment, the global tumor ablation market is segmented into surgical, laparoscopic and percutaneous. On the basis of the application, the global tumor ablation market is segmented into liver cancer, breast cancer, lung cancer, prostate cancer, and other cancer. On the basis of region the global tumor ablation market is segmented into Latin America, Europe, Asia Pacific, North America, and Middle East amp; Africa.

Download Free Report Sample Pages at https://www.acumenresearchandconsulting.com/request-sample/972

Radiofrequency led the technology segment in 2017 accounting for over 30.5% of the market share as this therapy finds applications in solid tumor removal. Percutaneous processes are anticipated to observe profitable growth over the forecast period due to rising demand for minimally invasive procedures offering faster recovery and higher safety.

Lung cancer is expected to witness lucrative development during the forthcoming. Sedentary lifestyle and increasing air pollution are backing to rising occurrence of lung cancer. North America captures overall tumor ablation industry. Key parameters boosting the regional market are growing occurrence of cancer in U.S. and Canada, easy compensation policies, and accessibility of quality healthcare.

North America captures the major market share in 2018 accounting for over 34.6% of its share and is projected to continue its dominance during the forthcoming. Main parameter contributing to development of this region comprise government support for high purchasing power parity, quality healthcare, availability of reimbursement, and growing occurrence of cancers in Canada and U.S.

Such as, in U.S., the (PPACA) Patient Protection and Affordable Care Act, also called as ObamaCare, encourages quality and affordability of health insurance and decreases the cost of healthcare for individuals and government. Government initiatives, for instance, Precision Medicine Initiative formulating tailored tactics on unique features of diseases, are aiding in improving the overall healthcare system, therefore increasing market development.

Europe captured the market share 24.5% of the global market share during the forecast period. Greater extent of public funding in Europersquo;s healthcare system has backed to this development. Furthermore, occurrence of target populace base paired with government support to control cancer captures to significant development of this region. Such as, formation of bodies, for instance, the European Cancer Observatory, produced consciousness about cancer.

Asia Pacific is anticipated to observe the profitable development forthcoming due to helpful government initiatives and improving healthcare infrastructure. Furthermore, economic growths in countries, for instance, China and India, are anticipated to aid drive the market development. Enormous populace base with low per capita income in the region captures to high need for reasonable treatment options.

The key players catering to the global tumor ablation market are Misonix, Inc., Covidien PLC, Boston Scientific Corporation, Angiodynamics, HealthTronics, EDAP TMS S.A., SonaCare Medical, Galil Medical, Inc., Medtronic Plc., and Neuwave Medical, Inc.

View Detail Report at https://www.acumenresearchandconsulting.com/tumor-ablation-market

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Tumor Ablation
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Tumor Ablation Market By Technologies
1.2.2.1. Global Tumor Ablation Market Revenue and Growth Rate Comparison By Technologies (2015-2026)
1.2.2.2. Global Tumor Ablation Market Revenue Share By Technologies in 2017
1.2.2.3. Radiofrequency
1.2.2.4. Microwave
1.2.2.5. Cryoablation
1.2.2.6. Irreversible Electroporation
1.2.2.7. Other Technologies
1.2.3. Tumor Ablation Market By Treatment
1.2.3.1. Global Tumor Ablation Market Revenue and Growth Rate Comparison By Treatment (2015-2026)
1.2.3.2. Surgical
1.2.3.3. Laparoscopic
1.2.3.4. Percutaneous
1.2.3.5. Others
1.2.4. Tumor Ablation Market By Application
1.2.4.1. Global Tumor Ablation Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.4.2. Liver Cancer
1.2.4.3. Breast Cancer
1.2.4.4. Lung Cancer
1.2.4.5. Prostate Cancer
1.2.4.6. Other Cancer
1.2.5. Tumor Ablation Market by Geography
1.2.5.1. Global Tumor Ablation Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Tumor Ablation Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Tumor Ablation Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Tumor Ablation Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Tumor Ablation Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Tumor Ablation Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Tumor Ablation Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Tumor Ablation Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global Tumor Ablation Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Tumor Ablation Major Manufacturers in 2017

CHAPTER 4. TUMOR ABLATION MARKET BY TECHNOLOGIES

4.1. Global Tumor Ablation Revenue By Technologies
4.2. Radiofrequency
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Microwave
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Cryoablation
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Irreversible Electroporation
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Other Technologies
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. TUMOR ABLATION MARKET BY TREATMENT

5.1. Global Tumor Ablation Revenue By Treatment
5.2. Surgical
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Laparoscopic
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Percutaneous
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Others
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. TUMOR ABLATION MARKET BY APPLICATION

6.1. Global Tumor Ablation Revenue By Application
6.2. Liver Cancer
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Breast Cancer
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Lung Cancer
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Prostate Cancer
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.6. Others Cancer
6.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA TUMOR ABLATION MARKET BY COUNTRY

7.1. North America Tumor Ablation Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Tumor Ablation Market Revenue Share Comparison, 2015 amp; 2026 (%)
7.3. U.S.
7.3.1. U.S. Tumor Ablation Market Revenue and Forecast By Technologies, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Technologies, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Technologies, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE TUMOR ABLATION MARKET BY COUNTRY

8.1. Europe Tumor Ablation Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Tumor Ablation Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Technologies, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Technologies, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Technologies, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Technologies, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Technologies, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC TUMOR ABLATION MARKET BY COUNTRY

9.1. Asia-Pacific Tumor Ablation Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Tumor Ablation Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Technologies, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Technologies, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Technologies, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Technologies, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Technologies, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Technologies, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA TUMOR ABLATION MARKET BY COUNTRY

10.1. Latin America Tumor Ablation Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Tumor Ablation Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Technologies, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Technologies, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Technologies, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST TUMOR ABLATION MARKET BY COUNTRY

11.1. Middle East Tumor Ablation Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Tumor Ablation Market Revenue Share Comparison, 2015 amp; 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Technologies, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Technologies, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Technologies, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA TUMOR ABLATION MARKET BY COUNTRY

12.1. Africa Tumor Ablation Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Tumor Ablation Market Revenue Share Comparison, 2015 amp; 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Technologies, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Technologies, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Technologies, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. Misonix, Inc.
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Covidien PLC
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Boston Scientific Corporation
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Angiodynamics
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. HealthTronics
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. EDAP TMS S.A.
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. SonaCare Medical
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Galil Medical, Inc.
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Medtronic Plc.
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Neuwave Medical, Inc.
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies
13.11. Others
13.11.1. Company Snapshot
13.11.2. Overview
13.11.3. Financial Overview
13.11.4. Type Portfolio
13.11.5. Key Developments
13.11.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

INQUIRY BEFORE BUYING at https://www.acumenresearchandconsulting.com/inquiry-before-buying/972

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report at https://www.acumenresearchandconsulting.com/buy-now/0/972

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 11-Jul-2019